Rare CT and MR imaging features of scirrhous hepatocellular carcinoma with gross specimen and pathologic correlation: Case report and review of the literature

Kim, 2007, Sclerosing hepatic carcinoma: helical CT features, Abdom Imaging, 32, 725, 10.1007/s00261-006-9174-0 Chen, 2014, Imaging features of scirrhous hepatocellular carcinomas, Chin J Radiol, 48, 43 Ishak, 2001, Tumors of the liver and intrahepatic bile ducts, 199 Bosman, 2010, 210 Omata, 1981, Sclerosing hepatic carcinoma: relationship to hypercalcemia, Liver, 1, 33, 10.1111/j.1600-0676.1981.tb00020.x Ishak, 1994 Matsuura, 2005, ‘Scirrhous’ type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1, Histopathology, 47, 382, 10.1111/j.1365-2559.2005.02230.x Kurogi, 2006, Clinicopathological study of scirrhous hepatocellular carcinoma, J Gastroenterol Hepatol, 21, 1470 Kang, 2012, Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images, Radiology, 264, 751, 10.1148/radiol.12112308 Asayama, 2006, Delayed-phase dynamic CT enhancement as prognostic factor for mass-forming intrahepaticcholangiocarcinoma, Radiology, 238, 150, 10.1148/radiol.2381041765 Jeong, 2013, Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation, AJR – Am J Roentgenol, 201, W603, 10.2214/AJR.12.10262 Namasivayam, 2007, Imaging of liver metastases: MRI, Cancer Imaging, 7, 2, 10.1102/1470-7330.2007.0002